The headline from Japan Times says it all: 'AI's race to transform the world before the money runs out.' The piece details how assumptions about future profits are driving unprecedented investment, while economists point out there's little evidence the technology will deliver returns to justify the spend. We've seen this pattern in health tech before. Grand visions. Massive capital. Patients still waiting for solutions that work today. That's exactly why Seven Sports built Amblyotube differently. No speculative roadmap. No 'coming soon' therapy. Amblyotube is a Meta Quest app available right now that delivers dichoptic visual training — a different image to each eye — while the user watches YouTube-style content. It's recreational. It's educational. And it's grounded in the established science of dichoptic therapy for amblyopia and visual coordination deficits. The contrast is stark: billions chasing an AI future that may or may not materialize, versus a $10-20 app on a headset millions already own,届ける実用
Product: https://www.meta.com/en-gb/experiences/amblyotube/25906906972338493/
Top comments (0)